Bruce Warshauer, M.D.
NPI 1831112689 · Specialist · Point Pleasant, NJ
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Bruce Warshauer, M.D. is a Specialist provider in Point Pleasant, NJ (NPI 1831112689).
Provider details
- NPI number
- 1831112689
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- MA40242 (NJ)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,964 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 604 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 581 | $89 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 315 | $59 |
| Punch Biopsy, First Skin Growth11104 | 117 | $122 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 109 | $125 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Imiquimod | 209 | 169 |
| Gentamicin Sulfate | 124 | 100 |
| Mupirocin | 124 | 103 |
| Betamethasone Valerate | 40 | 23 |
| Triamcinolone Acetonide | 37 | 27 |
| Mometasone Furoate | 27 | 25 |
| Econazole Nitrate | 26 | 14 |
| Nystatin | 26 | 14 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$216 across 9 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-25
- Last updated
- 2007-07-08
Frequently asked questions
- What is Bruce Warshauer's NPI number?
- Bruce Warshauer's National Provider Identifier (NPI) is 1831112689, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Bruce Warshauer's specialty?
- Bruce Warshauer is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Bruce Warshauer located?
- Bruce Warshauer's practice location on file with NPPES is 2424 Bridge Ave, Point Pleasant, NJ 08742-4335.
- What is Bruce Warshauer's phone number?
- The practice phone number listed in the NPPES registry for Bruce Warshauer is (732) 295-0100.
- Does Bruce Warshauer accept Medicare?
- Bruce Warshauer is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Bruce Warshauer's NPI active?
- Yes — Bruce Warshauer's NPI (1831112689) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.